RPP40P2

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RPP40P2 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RPP40P2 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RPP40P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPP40P2 expression acts as an unfavorable survival marker.

LUSC and SKCM are the cancer types where RPP40P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LUSCOSTertileII,III,IV0.1810.732.04018view →
SKCMDFSTertileAll0.1980.730.0019view →
Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RPP40P2–LUSC (OS)

Kaplan–Meier survival curve for RPP40P2 RNA-high vs -low samples in LUSC.

Open the LUSC breakdown →

Exploration